Synopsis:Leading Indian pharma firm with strong global presence, growing OTC focus, and robust US pipeline. Backed by solid financials and expansions, it targets FY26–27 growth, with brokerages maintaining a bullish outlook. India’s pharmaceutical sector, valued at...
The shares of the Pharma company, specializing in the manufacturing and supply of iodine derivatives and APIs, particularly focusing on iodine chemistry, are in focus upon signing a 5-year exclusive distribution agreement with Japan’s K Sakai & Company. With a...
This small-cap Pharma Stock, engaged in manufacturing and marketing pharmaceutical formulations and APIs, serving regulated and emerging markets with a focus on quality, compliance, and innovation, is in focus after management expected 50% growth in revenue and 100%...
During Thursday’s trading session, the shares of a global pharmaceutical company providing access to affordable and innovative medicines tumbled by nearly 2 percent on BSE, after CITI Research trimmed target price and recommended a “sell” rating on the...
Shares of a company involved in exporting, marketing & distributing finished formulations of pharmaceutical drugs and API surged nearly 3 percent on Tuesday, after the company announced record date for bonus issue in 1:1 ratio. With a market cap of Rs. 1,076...
During Friday’s trading session, shares of a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products surged by around 1 percent on the BSE to Rs. 522.95, with a market cap of Rs. 2,404 crores....
During Tuesday’s trading session, shares of a global biopharmaceutical company engaged in the manufacturing of biotechnology products and research services are in focus, after the company launched a Qualified Institutions Placement (QIP) to raise up to Rs. 4,500...
Shares of a leading pharmaceutical company rose nearly 2 percent in today’s trading session after the firm announced it had secured regulatory approval for its new diabetes drug. The development marks a significant milestone in the company’s efforts to expand its...
A leading pharmaceutical company witnessed an 8 percent surge in its stock price after unveiling ambitious plans to achieve 20 percent revenue growth, coupled with expectations of improved margins. The upbeat outlook has sparked strong investor interest, reflecting...
This small-cap Pharma Stock, engaged in manufacturing and R&D of pharmaceuticals, offering tablets, capsules, injectables, syrups, eye drops, and various formulations, jumped 7 percent after the company reported a net profit growth of 43,516 percent in the...
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
